Autolus Therapeutics plc (AUTL) stock
AUTLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/3020% below fair value
$1.06−0.03 (-2.75%)
Close on Nov 18, 2026Market cap $282.13MP/E –Yield –
Autolus Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Autolus Therapeutics's market cap was $328.69M on Nov 11, 2026, against $375.28M a year earlier. Over the last 5 years it ranged from $136.96M to $1.11B, with a median of $399.21M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $328.69M | -37.9% |
| 2025 | Dec 31, 2025 | $529.64M | -2.9% |
| 2024 | Dec 31, 2024 | $545.42M | -46.1% |
| 2023 | Dec 29, 2023 | $1.01B | +638.9% |
| 2022 | Dec 30, 2022 | $136.96M | -51.8% |
| 2021 | Dec 31, 2021 | $283.89M | +0.6% |
| 2020 | Dec 31, 2020 | $282.12M | -32.3% |
| 2019 | Dec 31, 2019 | $416.55M | -59.8% |
| 2018 | Dec 31, 2018 | $1.04B | – |
See a number that looks wrong?